In these days of terminally online transactions, it can feel like there isn’t all that much going on out there beyond what’s served to us via the algorithm. That’s why I love getting out and engaging ...

Objectification, hate, rape threats: the politicians debating online abuse mean well, but to truly understand, they need to see what I see If you’re anything like my parents, you probably wouldn’t ...

If you purchase an independently reviewed product or service through a link on our website, Variety may receive an affiliate commission. Lisa Rinna already has three novels under her belt but she’s ...

Macy is a writer on the AI Team. She covers how AI is changing daily life and how to make the most of it. This includes writing about consumer AI products and their real-world impact, from ...

Holy Trinity advanced to the Class 2A state championship after defeating Westminster Christian in a penalty shootout. Goalkeeper Dustin Strom made three saves in the shootout. Holy Trinity will play ...

The new Millionaire for Life lottery game held its first drawing on Sunday, Feb. 22, ending without a winner across more than two dozen states. The winning numbers for the first-ever drawing were 1-30 ...

The outrageous reality TV star has written a memoir — part evolution, part exorcism. She’s more than ready to tell you why. The outrageous reality TV star has written a memoir — part evolution, part ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› by Rosie Guerin, Abigail Keel, and Brenda Stolyar Apple is in its “affordable” ...

WICHITA, Kan. (KSNW) — Former KSN Chief Meteorologist Mike Smith joined current KSN Chief Meteorologist Lisa Teachman on Monday’s podcast. Smith began his career at KSN in the 1970s and continued into ...

A senior Pentagon official has offered more details on what triggered the dramatic falling-out between the US military and AI company Anthropic. According to a report by news agency Reuters, Emil ...

Silexion Therapeutics (NASDAQ: SLXN) is developing an RNA-based therapy designed to silence KRAS - the most coveted target in precision oncology - in pancreatic cancer, one of the deadliest and most ...